XCUR Logo

Exicure, Inc. (XCUR) 

NASDAQ
Market Cap
$49.56M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
167 of 960
Rank in Industry
114 of 550

Largest Insider Buys in Sector

XCUR Stock Price History Chart

XCUR Stock Performance

About Exicure, Inc.

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie Inc. to develop SNA-based treatments for hair loss disorders; and collaboration agreement with Ipsen S.A. to research, develop, and commercialize novel spherical nucleic acids for Huntington's disease …

Insider Activity of Exicure, Inc.

Over the last 12 months, insiders at Exicure, Inc. have bought $711,669 and sold $4.49M worth of Exicure, Inc. stock.

On average, over the past 5 years, insiders at Exicure, Inc. have bought $1.71M and sold $1.62M worth of stock each year.

Highest buying activity among insiders over the last 12 months: DGP Co., Ltd. (10 percent owner) — $711,669.

The last purchase of 237,223 shares for transaction amount of $711,669 was made by DGP Co., Ltd. (10 percent owner) on 2024‑09‑12.

List of Insider Buy and Sell Transactions, Exicure, Inc.

2024-09-12Purchase10 percent owner
237,223
26.8832%
$3.00$711,669+100.00%
2024-02-29Sale10 percent owner
3.4M
74.1245%
$1.32$4.49M-27.32%
2022-12-15Purchasedirector
3.4M
$1.60$5.44M+23.08%
2022-05-19Purchase
1.47M
1.7441%
$0.19$285,151-61.43%
2021-12-21Sale10 percent owner
1.27M
1.423%
$0.24$303,200-53.10%
2021-08-27PurchaseChief Accounting Officer
10,000
0.0114%
$1.38$13,800-86.04%
2020-06-12Sale
10,195
0.012%
$2.83$28,852-27.64%
2020-06-12Sale10 percent owner
10,195
0.012%
$2.83$28,852-27.64%
2020-03-13Purchasedirector
291,066
0.3405%
$1.21$352,859+77.31%
2020-03-12PurchaseChief Financial Officer
18,248
0.0224%
$1.40$25,591+60.69%
2020-03-12Purchase
15,000
0.0191%
$1.45$21,750+60.69%
2019-12-19Purchasedirector
727,000
0.8229%
$2.75$2M-22.94%
2019-08-02Purchasedirector
1M
1.0487%
$2.00$2M-15.25%
2019-08-02Purchasedirector
250,000
0.2622%
$2.00$500,000-15.25%
2019-08-02Purchase
25,000
0.0262%
$2.00$50,000-15.25%
2019-03-22Purchase
500
0.0012%
$2.30$1,150+16.00%
2019-03-21Purchase
1,000
0.0023%
$2.43$2,430+10.85%
2019-03-19PurchaseChief Executive Officer
7,000
0.0158%
$2.40$16,800+8.33%
2019-03-18Purchase
1,000
0.0023%
$2.40$2,400+11.11%
2019-03-13Purchase
2,200
0.005%
$2.50$5,500+4.00%

Insider Historical Profitability

<0.0001%
DGP Co., Ltd.10 percent owner
849223
32.591%
$19.0211
Mirkin Chad A.
11257629
432.0386%
$19.0261+22.72%
Muralidhar Bali
8449126
324.2555%
$19.0220<0.0001%
WALT DAVID Rdirector
2058777
79.0105%
$19.0230<0.0001%
Tompkins Mark N.
1825667
70.0644%
$19.0220

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.